Literature DB >> 27385249

Contrary To Conventional Wisdom, Physicians Abandoned A Breast Cancer Treatment After A Trial Concluded It Was Ineffective.

David H Howard1, Pamela R Soulos2, Anees B Chagpar3, Sarah Mougalian4, Brigid Killelea5, Cary P Gross6.   

Abstract

Conventional wisdom holds that physicians are slow to abandon ineffective medical practices. We evaluated this theory in the case of axillary lymph node dissection, a procedure to remove the lymph nodes near the breast to prevent the spread of breast cancer following breast-conserving surgery. A major trial conducted from 1999 to 2004, with results presented in 2010 and published in 2011, found that patients who met certain criteria could forgo axillary lymph node dissection. Using cancer registry data, we estimated that the proportion of patients undergoing axillary dissection declined by 32.6 percentage points after the trial was published. The decline began immediately after the trial was presented at a medical conference. The rapid decline in the use of axillary dissection belies the common belief that practice patterns are slow to change in response to new evidence, and it highlights the value of trials of established medical practices to patients and the health system. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Access To Care; Evidence-Based Medicine; Health Reform; Health Spending; Medical technology

Mesh:

Year:  2016        PMID: 27385249     DOI: 10.1377/hlthaff.2015.1490

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  9 in total

1.  Physician age and the abandonment of episiotomy.

Authors:  David H Howard; Jason Hockenberry
Journal:  Health Serv Res       Date:  2019-03-06       Impact factor: 3.402

2.  Barriers and Facilitators to De-Implementation of the Choosing Wisely® Guidelines for Low-Value Breast Cancer Surgery.

Authors:  Margaret E Smith; C Ann Vitous; Tasha M Hughes; Sarah P Shubeck; Reshma Jagsi; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-03-02       Impact factor: 5.344

3.  Risk Scores to Improve Quality and Realize Health Economic Gains in Perioperative Care.

Authors:  Karsten Bartels; Robert L Lobato; Cathy J Bradley
Journal:  Anesth Analg       Date:  2021-09-01       Impact factor: 6.627

Review 4.  Regional Nodal Management in the Setting of Up-Front Surgery.

Authors:  Lior Z Braunstein; Monica Morrow
Journal:  Semin Radiat Oncol       Date:  2022-07       Impact factor: 5.421

Review 5.  Addressing the problem of overtreatment in breast cancer.

Authors:  Linda M Pak; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2022-05-19       Impact factor: 3.627

6.  Evidence and implementation gaps in management of sentinel node-positive melanoma in the United States.

Authors:  Kristy K Broman; Joshua Richman; Smita Bhatia
Journal:  Surgery       Date:  2022-02-01       Impact factor: 4.348

7.  Policies and Practices to Address Cancer's Long-Term Adverse Consequences.

Authors:  Cathy J Bradley; Sara Kitchen; Smita Bhatia; Julie Bynum; Gwen Darien; J Leonard Lichtenfeld; Randall Oyer; Lawrence N Shulman; Lisa Kennedy Sheldon
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

8.  Physician variation in the de-adoption of ineffective statin and fibrate therapy.

Authors:  Alexander Everhart; Nihar R Desai; Bryan Dowd; Jeph Herrin; Lucas Higuera; Molly Moore Jeffery; Anupam B Jena; Joseph S Ross; Nilay D Shah; Laura Barrie Smith; Pinar Karaca-Mandic
Journal:  Health Serv Res       Date:  2021-02-10       Impact factor: 3.734

9.  Evidenced-Based Claims About Evidence.

Authors:  David H Howard
Journal:  MDM Policy Pract       Date:  2017-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.